Guru Ownership Trend
Guru Analysis for Immunome, Inc. (IMNM)
Immunome, Inc. (IMNM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.91 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $21.67 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 264.4%. Conversely, Cliff Asness reduced exposure by 37.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Immunome, Inc. (IMNM)
Major holders include Renaissance Technologies (RenTech) ($5.32 M), Cliff Asness ($249,618), Joel Greenblatt ($214,019). According to the latest reported data, 3 tracked investment managers collectively hold approximately 272,982 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $21.67 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited IMNM. The total reported sell value was $25.53 M.
Yes, 0 managers opened new positions in IMNM, and 1 increased their existing holdings. The total reported buy value was $3.86 M.